Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.

NCT04587882 · ClinicalTrials.gov registry record · NA

Virtual AppLication-supported ENvironment To INcrease Exercise During Cardiac Rehabilitation Study

A NA study of Cardiovascular Diseases and Heart Diseases, sponsored by University of Michigan.

Completed
Registry status
NA
Development phase
223
Enrollment target
2
Study locations

NCT04587882 is a NA study of Cardiovascular Diseases and Heart Diseases that has completed, run by University of Michigan. The registered enrollment target is 223 participants, below the 26,974-participant average among 300 other Cardiovascular Diseases trials with a reported enrollment target (99% lower). The trial reports 2 study locations across 1 state.

View on ClinicalTrials.gov ↗

View your shortlist →

The verdict

NCT04587882, a NA study of Cardiovascular Diseases and Heart Diseases, has completed, sponsored by University of Michigan.

COMPLETED
Registry status
NA
Development phase
223 participants
Enrollment target
2
Study locations

Study Summary

The researchers are trying to determine whether a smartwatch and a mobile application, which together deliver activity and goal setting notifications, can increase activity levels for patients enrolled in cardiac rehabilitation.

Interventions

  • BEHAVIORAL Control
  • BEHAVIORAL Telehealth

Study Locations (2)

Michigan

  • University of Michigan - Ann Arbor
  • Spectrum Health - Grand Rapids

Trial Details

FieldValue
Enrollment Target 223 participants
Start Date 2020-10-23
Est. Completion 2022-10-25
Phase NA

Sponsor

University of Michigan

1,327 total trials

What the Registry Record Tells You About NCT04587882

The ClinicalTrials.gov registry entry for NCT04587882 describes a study currently listed as completed, categorized as NA. The registered enrollment target is 223 participants, a figure that helps gauge the scale of data the investigators plan to collect, below the 26,974-participant average among 300 other Cardiovascular Diseases trials with a reported enrollment target (99% lower). The listed sponsor is University of Michigan, which has 1,327 total studies on file at ClinicalTrials.gov.

The record links to 2 conditions, with Cardiovascular Diseases appearing as the primary indexed condition, and to 2 interventions - of which Control is the first listed.

NCT04587882 reports 2 study locations spanning 1 distinct geographic area - top geographies include Michigan.

Frequently Asked Questions

What is clinical trial NCT04587882 about?

NCT04587882 is a clinical study titled "Virtual AppLication-supported ENvironment To INcrease Exercise During Cardiac Rehabilitation Study". The researchers are trying to determine whether a smartwatch and a mobile application, which together deliver activity and goal setting notifications, can increase activity levels for patients enrolled in cardiac rehabilitation.

What is the current status of trial NCT04587882?

This trial is currently completed. It is a NA study. The enrollment target is 223 participants. The study started on 2020-10-23. Estimated completion is 2022-10-25.

What conditions does trial NCT04587882 study?

This clinical trial studies the following conditions: Cardiovascular Diseases, Heart Diseases.

What interventions are being tested in trial NCT04587882?

The interventions under investigation include: Control (BEHAVIORAL), Telehealth (BEHAVIORAL).

Who is sponsoring clinical trial NCT04587882?

This trial is sponsored by University of Michigan, which has 1,327 total clinical trials registered on ClinicalTrials.gov.

Where is trial NCT04587882 being conducted?

This trial has 2 study locations across Michigan. Contact the study sites directly through ClinicalTrials.gov for enrollment availability.

Similar trials for Cardiovascular Diseases

Matched on the same primary condition, ranked to surface studies in the same phase first, then by recruiting status, no relevance scoring or editorial curation.

Data sourced from official public datasets. See our methodology for details. Retrieved and formatted by PlainTrial Editorial

Every figure on PlainTrial is rendered directly from the ClinicalTrials.gov registry, no number is typed in by an editor. This page mirrors this trial's own ClinicalTrials.gov registry record, live from the dataset. See our editorial standards & corrections policy, the methodology behind these numbers, or report a data error.